Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

Insilico Medicine advances AI drug for IPF to Phase III trials

Large international study validates genetic risk score for diagnosing and predicting pulmonary fibrosis outcomes

Researchers have validated a polygenic risk score tool that can help diagnose idiopathic pulmonary fibrosis (IPF) and predict which patients

New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'

Pancreatic cancer has an extremely low survival rate (97% mortality within 5 years for metastatic cases) due to late detection and the forma

FDA Clears NIH-Supported Gene Therapy MMA-101 for First Human Trial in Rare Metabolic Disorder

The FDA has cleared an Investigational New Drug (IND) application for MMA-101, an AAV-based gene therapy candidate developed with NIH suppor

Mayo Clinic study finds genetic testing and telomere evaluation transform pulmonary fibrosis care

A new Mayo Clinic study demonstrates that integrating telomere length evaluation and genetic testing into pulmonary care significantly chang

Selective ROCK2 inhibitor TDI01 shows anti-fibrotic potential in liver fibrosis preclinical and clinical studies

This article presents research on liver fibrosis, identifying that upregulation of ROCK2 in liver endothelial cells and perivascular hepatic